BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 27002676)

  • 1. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.
    Campos S; Gomes D; Sofia C
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):661-6. PubMed ID: 27002676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.
    Jeffries MA; Kazanjian S; Wilson M; Punch J; Fontana RJ
    Liver Transpl Surg; 1998 Sep; 4(5):416-23. PubMed ID: 9724480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
    Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis.
    Jindal A; Mukund A; Kumar G; Sarin SK
    Liver Int; 2019 Nov; 39(11):2164-2173. PubMed ID: 31356712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.
    Maleux G; Nevens F; Wilmer A; Heye S; Verslype C; Thijs M; Wilms G
    Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.
    Gordon FD; Anastopoulos HT; Crenshaw W; Gilchrist B; McEniff N; Falchuk KR; LoCicero J; Lewis WD; Jenkins RL; Trey C
    Hepatology; 1997 Jun; 25(6):1366-9. PubMed ID: 9185754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.
    Wilputte JY; Goffette P; Zech F; Godoy-Gepert A; Geubel A
    Acta Gastroenterol Belg; 2007; 70(1):6-10. PubMed ID: 17619531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.
    Hidajat N; Vogl T; Stobbe H; Schmidt J; Wex C; Lenzen R; Berg T; Neuhaus P; Felix R
    Acta Radiol; 2000 Sep; 41(5):474-8. PubMed ID: 11016769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
    Allaire M; Walter A; Sutter O; Nahon P; Ganne-Carrié N; Amathieu R; Nault JC
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):249-263. PubMed ID: 31662286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites.
    Andrade RJ; Martin-Palanca A; Fraile JM; Alcantara R; Carmona C; Medina MC; Muñoz V; Melgarejo F
    J Clin Gastroenterol; 1996 Jun; 22(4):305-7. PubMed ID: 8771428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.
    Siegerstetter V; Deibert P; Ochs A; Olschewski M; Blum HE; Rössle M
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):529-34. PubMed ID: 11396532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
    Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
    Am J Gastroenterol; 2010 Mar; 105(3):635-41. PubMed ID: 19904245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.